GlaxoSmithKline Slashes Prices of Key Drugs For Africans
GlaxoSmithKline
GlaxoSmithKline (GSK) a leading international Pharmaceutical company has announced a 40 percent reduction for antibiotics prices in Kenya, Uganda and Tanzania. Oral formulations of Augmentin would reduce by 40 percent while that of Zinnat would have a 30 percent fall. GSK Managing Director John Musunga said the move was to help in the fight against bacterial infection in east Africa.
Musungu further added the drop in prices will be effective this month and was as a result of pressure from medical practitioners and the governments in the region to bring the medical cost down. The two drugs represent a 50 percent turnover for the firm. GSK first reduced cost of its patented medicines in the region by more than half in April last year. The copyrighted drugs were reduced by between 60 and 80 percent. Patented medicines are those that GSK has exclusive global rights to manufacture and sell for atleast15 years before another company starts to formulate similar products. The organization is one of the leading research based pharmaceutical and healthcare companies worldwide.
© 2010, Paul Mwaura. All rights reserved.
I NEED AMEDICINE OF GLAXO SMITH COMPANY AND HOW WE CONTACT TO YOU AND PLEASE SEND ME YOUR LIST PRICE AND PRODUCTS AND YOU HAVE DISTRIBUTE ADDRESS OF KENYA.
I STAY IN EAST AFRICA
I am Interested in starting a chemist outlet for human medicine,kindly assist me with your names of drugs you manufacture and the cost of buying them. My number is 0722112871 i reside in Nairobi.Thank you
Regards
Andrew Mwawaza.
Pingback: The struggle to prevent import of counterfeit drugs in Ghana « Ghanaian Scoop